PALM BEACH, Florida, April 29, 2020 /PRNewswire/ — It seems that as the global cannabis market continues to ebb and flow, its tentacles are reaching into traditionally unrelated markets such as cosmetics, biopharmaceuticals, food & agriculture and the beverages markets. The worldwide cosmetics market is projected at $758 billion by 2025; the global biopharmaceuticals market is estimated to reach $389 billion by 2024; the global food & agriculture technology and products market is estimated at $729 billion by 2023; and the worldwide food and beverage market is estimated to reach $9.5 trillion by 2022. These are fertile grounds for cannabis market expansion and M&A activity. The cannabis market itself, is projected to reach $89 billion by 2024 and to record a robust CAGR of 14.5% during that time. Mordor Intelligence says that the medicinal properties of cannabis, increasing the legalization of cannabis, and increasing advances in genetic development and intellectual property of cannabis are and will be the drivers in the market. Medicinal cannabis accounts for the majority share of the cannabis market revenues. Their report said that the increasing legalization of cannabis is and will continue to be the most important event to continue driving the market with the introduction of new consumer products in the pain relief, skincare, nutraceuticals, pharmaceuticals, agriculture, and veterinary fields. Major medical discoveries are triggering an eruption of new products in consumer-packaged goods (CPG) – reaching millions of consumers across different demographics – bringing CBD into the mainstream. Active cannabis companies in the markets this week include: Pressure BioSciences, Inc. (OTCQB: PBIO), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), Tilray, Inc. (NASDAQ: TLRY), Aphria Inc. (NYSE: APHA) (TSX: APHA), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON).